Latest National Heart, Lung, and Blood Institute Stories
Members of six of the worldâ€™s largest health agencies have agreed to work together to combat mankindâ€™s deadliest diseases.
SANTA CRUZ, Calif., June 16 /PRNewswire/ -- Six prestigious members of the National Institutes of Health have joined Bio Career Center (www.BioCareerCenter.com), the nation's leading online jobs board and careers site for life science professionals. The NIH has the highest number of post-doctoral professionals at any scientific institute in the country.
Government investigators are again turning to heart attack survivors, enrolling them in a controversial new study of an alternative treatment of high dose vitamin supplements and chelation, a lead poisoning treatment that has not been proven safe or effective for heart disease.
Individuals with heart disease are twice as likely to suffer from depression as the general population, an association the medical community has largely been unable to explain.
New research supports the findings of a landmark drug comparison study published in 2002 in which a diuretic drug or â€œwater pillâ€ outperformed other medications for high blood pressure. A scientific team including investigators from The University of Texas Health Science Center at Houston reports the findings in the May 11 issue of the Archives of Internal Medicine.
An international research team has identified a number of unsuspected genetic variants associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension (high blood pressure), suggesting potential avenues of investigation for the prevention or treatment of hypertension.
WASHINGTON, April 23 /PRNewswire/ -- The Washington, D.C.
Scientists have discovered a link between two genetic variants and an increased risk of ischemic stroke.
A type of surgery which reshapes the scarred left ventricle, the main pumping chamber of the heart, and is often done in conjunction with heart bypass, not only failed to reduce deaths and hospitalizations in heart failure patients but also did not improve patients' quality of life compared to bypass alone after four years of follow-up, according to the results of a large international clinical trial funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of...
New results from the Womenâ€™s Health Initiative (WHI) Observational Study provide additional evidence that aspirin may reduce the risk of death in postmenopausal women who have heart disease or who have had a stroke.